Design, rationale, and baseline findings from a patient-centered randomized trial of technology-enabled team care: the heart-2-heart BP control partners study
Contemporary Clinical Trials · 2026-11 · 170 · 108469
DOI: 10.1016/j.cct.2026.108469 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2026-11. Verfasst von Doyle M Cummings und 9 weiteren Autor:innen. Beteiligte Einrichtung: East Carolina University, USA. Electronic address: cummingsd@ecu.edu. Hauptthemen laut MEDLINE: Hypertension, Antihypertensive Agents, Blood Pressure Monitoring, Ambulatory, Patient Care Team. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Patient-Centered Outcomes Research Institute.
Abstract (Originalsprache)
BACKGROUND: Evidence demonstrates that home blood pressure (BP) monitoring improves control; however, the impact of supplementing home BP monitoring with team care is less well described. PURPOSE: To assess the impact of combining cellular-enabled home BP monitoring with pharmacist-led team care relative to usual care for patients with uncontrolled hypertension. METHODS: Guided by patients and caregivers, researchers worked with 19 primary care practices in North Carolina (NC) to enroll diverse adult patients with uncontrolled hypertension and randomize them to technology-enabled team care (TTC) or enhanced usual care (EUC). Both groups were asked to check their home BP using a cellular-enabled monitor. TTC arm patients received regular telephonic BP management from a clinical pharmacist who reviewed home BP readings and worked with the patient's physician/provider to adjust anti-hypertensive medicines, provide brief nutrition and physical activity counseling, and make referrals for unmet social needs. RESULTS: We randomized 719 patients (EUC n = 362; TTC n = 357); mean age 62.3 ± 13.5 years, 45.6% men, 38.4% Black, average systolic blood pressure (SBP) 156.7 (±14.4) mmHg with no statistically significant differences between treatment arms. Mean BMI was 32.5 ± 7.4; mean Patient Activation Measure (PAM) Score was 70.45; mean Social Vulnerability Index score was 0.52; 66% were on 2 or more anti-hypertensives at baseline; and 16% reported less than perfect medication adherence. CONCLUSION: Combining cellular-enabled home BP monitoring and pharmacist-led team care for diverse patients with uncontrolled hypertension in primary care may have great potential to improve BP control. This trial is registered at ClinicalTrials.gov; registration number = NCT05809713.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- East Carolina University, USA. Electronic address: cummingsd@ecu.edu.
- University of North Carolina at Chapel Hill, USA.
- East Carolina University, USA.
- Virginia Commonwealth University, USA.
- University of Alabama at Birmingham, USA.
Förderung
- Patient-Centered Outcomes Research Institute
Zitieren
APA
Cummings, D. M., Halladay, J., Warner, C., Richman, E., Hart, S., Sastre, L., Pullen-Smith, B., Peri, K., Howard, G., & Heart to Heart Study Writing Group (2026). Design, rationale, and baseline findings from a patient-centered randomized trial of technology-enabled team care: the heart-2-heart BP control partners study. Contemporary Clinical Trials, 170, 108469. https://doi.org/10.1016/j.cct.2026.108469
Vancouver
Cummings DM, Halladay J, Warner C, Richman E, Hart S, Sastre L, et al. Design, rationale, and baseline findings from a patient-centered randomized trial of technology-enabled team care: the heart-2-heart BP control partners study. Contemporary Clinical Trials. 2026;170:108469. doi:10.1016/j.cct.2026.108469
BibTeX
@article{Cummings2026,
author = {Cummings, Doyle M and Halladay, Jacqueline and Warner, Courtney and Richman, Erica and Hart, Stephanie and Sastre, Lauren and Pullen-Smith, Barbara and Peri, Kalyani and Howard, George and Heart to Heart Study Writing Group, Heart to Heart Study Writing Group},
title = {Design, rationale, and baseline findings from a patient-centered randomized trial of technology-enabled team care: the heart-2-heart BP control partners study},
journal = {Contemporary Clinical Trials},
year = {2026},
volume = {170},
pages = {108469},
doi = {10.1016/j.cct.2026.108469}
}
EUVIMED